Indian Shipping sector to benefit from the new chartered ship between Kollam and Kochi

Posted by Ankita Palit On May - 23 - 2013

Indian shipping sector is expected to witness a strong connectivity between coastal and inland waterways in the State of Kerala. The state will get a 205 km Kollam-Kottapuram National Waterway III by Nov 2013. This initiative will provide a tremendous boost to efforts being made to shift cargo movement from congested and risky roads to [...]

GE launches innovative technology in Indian medical device market

Posted by sushmita sengupta On May - 22 - 2013

GE Healthcare has very recently launched its 1st healthcare technology experiential lounge on wheels under its Mission Healthier India in Coimbatore. The entire set up has been built at a cost of INR 4 mn that comprises of equipment such as ECG, scan, critical tools and infant care technologies. The mission was focused at upliftment [...]

Indian healthcare market gets its 1st ever indigenous rotavirus vaccine

Posted by sushmita sengupta On May - 15 - 2013

Indian healthcare industry will very soon launch its 1st completely indigenous and affordable rotavirus diarrhoea vaccine that took almost 28 years of hard work. The results of the Phase III clinical trial of the Rotavac vaccine was announced at an international conference that declared efficiency level at 56% in the 1st year of life. The [...]

Transportation & logistics market to see more divestment by Gati

Posted by Ankita Palit On May - 14 - 2013

Gati Ltd, one of leading player in the transportation & logistics market has sold 40% of its stake in Gati Ship to Riba Constructions. The deal was worth INR 80 mn which is expected to be complete by June 2013. The express distribution and supply chain solutions provider has plans to divest further in the [...]

Biocon and Trinity collaborate to encourage genetic research

Posted by sushmita sengupta On May - 14 - 2013

Bengaluru based Biocon has entered into a partnership with Dublin-based Trinity College to support Indian students in genetic research. Biocon will sponsor two annual sponsorships that would give meritorious candidates an opportunity to work in Trinty College laboratories. The sponsorship program has been especially designed to encourage innovation in the field of biotechnology. The sponsorship [...]

Research On India Blog

Mankind plans to foray into chronic drug business

Posted by sushmita.sengupta On July - 19 - 2012

Delhi based Mankind Pharma Ltd. is planning to enter the chronic drug segment to raise its turnaround and profit margin. The company is in plans to enter diabetes and cardiovascular drug segment within FY 2012-13 by launching as many as 15-16 products. The company currently has products in consumer brand category and acute disease pharmaceutical that last for a short duration and require therapies like anti-infectives, pain-killers or analgesics but are poor revenue earners because of its low price.

The company currently being positioned 7th in the drug market is targeting 2nd or 3rd position in the next 3-4 years for which it has strategically planned to penetrate in the chronic drugs segment thereby enabling the company to earn higher revenue.

Healthcare, Market Insights

Leave a Reply

Presentation

Ceramic Tiles Market in India Sample
View more presentations from Research on India.

Tags

acquisition bangalore beer beverage cargo DTH Education electricity energy Entertainment expansion food government gujarat healthcare higher hospital India investment IPO Joint Venture Latest Market Research logistics media medical micro mobile mumbai MVAS nuclear online outlets pe power reliance renewable retail solar solar power stake Telecom India value VAS warehousing wind